Ozone Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-06-2024
- Paid Up Capital ₹ 1.00 M
as on 22-06-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 48521.93%
(FY 2023)
- Profit 151.05%
(FY 2023)
- Ebitda 247.91%
(FY 2023)
- Net Worth 4.78%
(FY 2023)
- Total Assets 30.97%
(FY 2023)
About Ozone Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Manpreet Singh and Gagandeep Kaur serve as directors at the Company.
- CIN/LLPIN
U73100DL2009PTC188047
- Company No.
188047
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ozone Biotech Private Limited offer?
Ozone Biotech Private Limited offers a wide range of products and services, including Laboratory & Lab Equipment, Laboratory Chamber, Prefabricated Houses, Net House, Electric Circuit Components & Spares, Electronic Timers, Industrial Air Conditioner & Devices, Air Conditioner Parts, Laboratory Furniture, Process Control Systems & Equipments.
Who are the key members and board of directors at Ozone Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manpreet Singh  | Director | 02-Mar-2009 | Current |
| Gagandeep Kaur | Director | 25-Feb-2013 | Current |
Financial Performance of Ozone Biotech.
Ozone Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48521.93% increase. The company also saw a substantial improvement in profitability, with a 151.05% increase in profit. The company's net worth moved up by a moderate rise of 4.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ozone Biotech?
In 2023, Ozone Biotech had a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ozone Biotech?
Unlock and access historical data on people associated with Ozone Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ozone Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ozone Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
